CHLOROPTIC-P S.O.P. Drug Patent Profile
✉ Email this page to a colleague
When do Chloroptic-p S.o.p. patents expire, and what generic alternatives are available?
Chloroptic-p S.o.p. is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in CHLOROPTIC-P S.O.P. is chloramphenicol; prednisolone. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; prednisolone profile page.
Summary for CHLOROPTIC-P S.O.P.
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLOROPTIC-P S.O.P. at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROPTIC-P S.O.P.
US Patents and Regulatory Information for CHLOROPTIC-P S.O.P.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CHLOROPTIC-P S.O.P. | chloramphenicol; prednisolone | OINTMENT;OPHTHALMIC | 061188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |